| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/1992 | EP0491438A1 Contraceptive regimen |
| 06/24/1992 | EP0491415A1 Low estrogen oral contraceptives |
| 06/24/1992 | EP0491281A1 A 4-hydroxypyridine derivative, method for preparing the same, and a pharmaceutical composition comprising the same |
| 06/24/1992 | EP0491263A1 Phenylalkylaminoalkyl compounds; process for their preparation and pharmaceutical compositions containing same |
| 06/24/1992 | EP0491243A1 Alkylaminoalkylamino and -ether compounds as well as processes and intermediates for their preparation, and medicaments containing these compounds |
| 06/24/1992 | EP0491226A1 Substituted pyridyl-dihydroxyheptenoic acid and its salts |
| 06/24/1992 | EP0491218A1 Benzodiazepinones |
| 06/24/1992 | EP0491114A1 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity |
| 06/24/1992 | EP0491103A1 Compositions for therapeutic use comprising organogermanium derivatives |
| 06/24/1992 | EP0491094A1 Felbamate for treating Lennox-Gastaut syndrome |
| 06/24/1992 | EP0491061A1 Use of enalapril and perindopril as prolactin-lowering medicament |
| 06/24/1992 | EP0491053A1 Water-soluble bis-dioxopiperazine derivatives with antitumoral properties |
| 06/24/1992 | EP0491041A1 Antiviral drug |
| 06/24/1992 | EP0491018A1 Use of taurolidine and/or taurultam for the treatment of tumours |
| 06/24/1992 | EP0490995A1 Method for producing soluble glucans |
| 06/24/1992 | EP0490962A1 Antipsychotic 1-cycloalkylpiperidines |
| 06/24/1992 | EP0490944A1 Transmucosal dosage form. |
| 06/24/1992 | EP0490920A1 Pharmaceutical preparation binding with gastric acid. |
| 06/24/1992 | EP0490919A1 Cytoprotective fatty moiety compounds |
| 06/24/1992 | EP0490916A1 Compositions and methods of manufacture of oral dissolvable medicaments. |
| 06/24/1992 | EP0490901A1 Novel spirofurane derivatives |
| 06/24/1992 | EP0462207A4 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| 06/24/1992 | EP0402369A4 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
| 06/24/1992 | EP0396617B1 Paramagnetic compounds |
| 06/24/1992 | CN1062171A Process for preparing sulphate derivative of galactan extracted from klebsiella |
| 06/24/1992 | CN1062145A Azasteroid compounds for treatment of prostatic hypertrophy, their preparation and use |
| 06/24/1992 | CN1062143A Condensed heterocyclic compouds, their production and use |
| 06/24/1992 | CN1062142A Substituted dibenz-thiocinones, process for their preparation and their use in medicaments |
| 06/24/1992 | CN1062141A Process for preparing 1,5-benzothiazepine derivatives |
| 06/24/1992 | CN1062140A Process for preparing benzoxazin-and thiazin compounds |
| 06/24/1992 | CN1062138A Synergism of hiv reverse transcriptase inhibitors |
| 06/24/1992 | CN1062088A Preparation technology of cold resistant panacla tablet |
| 06/24/1992 | CN1017154B Tetracyclic indole derivatives |
| 06/24/1992 | CN1017152B Preparation for cardiotonic tricyclic imidazolones |
| 06/24/1992 | CN1017150B Preparation of cardrotonic heterocyclic oxazolones |
| 06/23/1992 | WO1992011279A1 D-HOMO-(16-EN)-11β-ARYL-4-ESTRENES, PROCESS FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS |
| 06/23/1992 | WO1992011278A1 14β-H-, 14- AND 15-EN-11β-aryl-4-ESTRENES |
| 06/23/1992 | WO1992011277A1 6,7-MODIFIED 11β-ARYL-4-ESTRENES |
| 06/23/1992 | WO1992011014A1 10-cyanomethylene-4-piperazine-1-yl)-pyrrolo[4,3e]benzoazepines for relieving migraine |
| 06/23/1992 | US5124473 Polycyclic aromatic derivatives, process for preparing the same and pharmaceutical and cosmetic compositions containing the same |
| 06/23/1992 | US5124455 Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
| 06/23/1992 | US5124442 Process for preparing azt (3'-azido-3'-deoxy-thymidine) and related compounds |
| 06/23/1992 | US5124392 Administering a steroid |
| 06/23/1992 | US5124360 Administering D-chiroinositol to achieve reduction in blood glucose level |
| 06/23/1992 | US5124358 Effect of transglutaminase inhibition on microfilariae development and macrofilariae viability |
| 06/23/1992 | US5124357 Containing lysine; increases weight gain and feed utilization |
| 06/23/1992 | US5124356 Topical application of esters and amides of retinoic acid |
| 06/23/1992 | US5124352 Cardiovascular disorders |
| 06/23/1992 | US5124351 Containing copper chelate of nitrilotriacetic acid or bis-thiosemicarbazone |
| 06/23/1992 | US5124350 Leukotriene b4 antagonists |
| 06/23/1992 | US5124346 Synergistic combinations in the treatment of anxiety |
| 06/23/1992 | US5124342 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
| 06/23/1992 | US5124340 Administering dihydropyridine compound |
| 06/23/1992 | US5124339 2-(aminoethylamino) pyridine composition |
| 06/23/1992 | US5124338 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 06/23/1992 | US5124337 Treating atherosclerosis |
| 06/23/1992 | US5124336 Azabenzimidazole derivatives which are thromboxane receptor antagonists |
| 06/23/1992 | US5124335 Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists |
| 06/23/1992 | US5124330 (E)-ethyl 3-(4-chloro-α-(4-methyl-1-piperazinyl)benzyl)cinnamate used for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 06/23/1992 | US5124327 Administering in the prevention and treatment of AIDS |
| 06/23/1992 | US5124326 Antiarrhythmic, hypotensive agents; diuretics |
| 06/23/1992 | US5124325 Administering to inhibit bone resorption |
| 06/23/1992 | US5124323 2-(quinoliniumalkyl and isoquinoliniumalkyl) phenyl carbapenem antibacterial agents |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | US5124321 Treating estrogen deficiency symptoms, preventing pregnancy |
| 06/23/1992 | US5124319 Administering for treatment of neuropathological disorders induced by overstimulation of excitatory amino acid receptors |
| 06/23/1992 | US5124318 Hermetic sealed container |
| 06/23/1992 | US5124158 Applying 2-pyridylmethylthio- and sulfinyl-benzimidazoles |
| 06/23/1992 | US5124157 Using adhesive skin patch |
| 06/23/1992 | US5124154 Aminosteroids for ophthalmic use |
| 06/23/1992 | US5124152 Parenteral formulation of metolazone |
| 06/23/1992 | US5124147 Mixture of antagonist to platelet activating factor and antibody |
| 06/23/1992 | US5124146 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/23/1992 | US5124144 Polyethylene glycol, sodium sulfate, sodium bicarbonate, sodium and potassium chlorides, saccharin, flavoring, retains isotonicity good taste |
| 06/23/1992 | US5124083 3-substituted and 3,3-disubstituted 4-oxoretinoic acids and their esters |
| 06/23/1992 | US5124081 Amphiphilic lipid compounds, process for their preparation and their applications especially in cosmetics and dermopharmacy |
| 06/23/1992 | CA2099018A1 6,7-modified 11.beta.-aryl-4-estrenes |
| 06/23/1992 | CA2099016A1 14.beta.-h-, 14- and 15-en-11.beta.-aryl-4-estrenes |
| 06/23/1992 | CA2098815A1 10-cyanomethylene-4-(1-piperazinyl)pyrrolo-[4,3-e] benzazepines for controlling migraine |
| 06/23/1992 | CA1304093C Imidazolidines substituted by a hydroxymethyl radical and a substituted phenyl radical, process for their preparation, their application as medecines, pharmaceutical compounds containing them and an intermediate compound for their preparation |
| 06/23/1992 | CA1304091C 2,6-bis(chloromethyloxy-carbonyloxymethyl)-pyridine and a process for preparing same |
| 06/23/1992 | CA1304086C Guanidine carboxylic acid esters, processes for their preparation and pharmaceutical preparations containing these compounds |
| 06/23/1992 | CA1304082C Benzoxazine compounds and pharmaceutical use thereof |
| 06/23/1992 | CA1304080C Optically active pyridobenzoxazine derivatives and intermediates thereof |
| 06/23/1992 | CA1303999C Filtrating cosmetic composition in the form of an oil-in-water emulsion comprising a uv-a and a uv-b filter and its use for protecting the skin against ultra-violet rays |
| 06/23/1992 | CA1303997C Combination of pyrimidine and hydrocortisone derivatives to induce and stimulate hair growth and reduce hair loss |
| 06/23/1992 | CA1303996C Methods for treatment of sundamaged human skin with retinoids |
| 06/23/1992 | CA1303994C2 Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds |
| 06/23/1992 | CA1303993C Pharmaceutical compositions containing ranitidine |
| 06/23/1992 | CA1303992C Stable injectable solutions of vinca dimer salts |
| 06/23/1992 | CA1303991C Composition and method for delivering a steroid active ingredient |
| 06/23/1992 | CA1303990C Solubilization of hydrophobic materials using lysophospholipids |
| 06/23/1992 | CA1303986C Anti-proliferative action of dsrnas on tumor cells |
| 06/22/1992 | WO1992011262A1 1-(4-acylaminophenyl)-7,8-methylenedioxy-5h-2,3-benzo-diazepine derivatives and acid addition salts thereof, pharmaceutical compositions containing them and process for preparing same |
| 06/22/1992 | WO1992011260A1 Xanthine derivatives |
| 06/22/1992 | WO1992011232A1 Chelating agents |
| 06/22/1992 | WO1992011012A1 Use of quisqualate-receptor antagonists for treating parkinson's disease |
| 06/22/1992 | CA2098846A1 Xanthine derivatives |
| 06/22/1992 | CA2098712A1 Chelating agents |
| 06/22/1992 | CA2098291A1 1-(4-acylaminophenyl)-7,8-methylenedioxy-5h-2,3-benzo- diazepine derivatives and acid addition salts thereof, pharmaceutical compositions containing them and process for preparingsame |